BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 1 , Pages 28-35 , January 2010

Efficacy of ECT in Chronic, Severe, Antidepressant- and CBT-Refractory PTSD: An Open, Prospective Study

  • Mushtaq A. Margoob

      Affiliations

    • Department of Psychiatry, Government Medical College, Srinagar, India
    • ,
  • Zaffar Ali

      Affiliations

    • Mount Sinai School of Medicine, New York, New York; J. J. Peters Veterans Affairs Medical Center, Bronx, New York
    • ,
  • Chittaranjan Andrade

      Affiliations

    • Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India
    • Corresponding Author InformationAddress reprint requets to: Chittaranjan Andrade, MD, Professor in Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore 560 029, India.

Received 16 February 2009 ,Revised 24 April 2009 ,Accepted 27 April 2009.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994;
  2. Hamner MB, Robert S, Frueh BC. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr. 2004;9:740–752
  3. Schoenfeld FB, Marmar CR, Neylan TC. Current concepts in pharmacotherapy for posttraumatic stress disorder. Psychiatr Serv. 2004;55:519–531
  4. Ipser J, Seedat S, Stein DJ. Pharmacotherapy for post-traumatic stress disorder - a systematic review and meta-analysis. S Afr Med J. 2006;96:1088–1096
  5. Zhang W, Davidson JR. Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies. Expert Opin Pharmacother. 2007;8:1861–1870
  6. Brady KT, Killeen TK, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000;61(Suppl 7):22–32
  7. American Psychiatric Association . The Practice of ECT: Recommendations for Practice, Training, and Privileging. Task Force Report on ECT. Washington, DC: American Psychiatric Press; 2001;
  8. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, et al. Work Group on ASD and PTSD; Steering Committee on Practice Guidelines Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(11 Suppl):3–31
  9. Helsley S, Sheikh T, Kim KY, Park SK. ECT Therapy in PTSD. Am J Psychiatry. 1999;156:494–495
  10. Hanretta AT, Malek-Ahmadi P. Combined use of ECT with duloxetine and olanzapine: a case report. J ECT. 2006;22:139–141
  11. Watts BV. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder. J ECT. 2007;23:93–95
  12. Hollander E, Simeon D. Anxiety Disorders. In:  Hales RE,  Yudofsky SG editor. Textbook of Clinical Psychiatry. 4th ed. Washington, DC: American Psychiatric Publishing, Inc; 2003;p. 543–630
  13. Post RM, Weiss SR, Smith M, Li H, McCann U. Kindling versus quenching: implications for the evolution and treatment of posttraumatic stress disorder. Ann N Y Acad Sci. 1997;821:285–295
  14. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT. 1999;15:5–26
  15. de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res. 2006;40:550–567
  16. Fink M. Electroshock: Restoring the Mind. New York: Oxford University Press; 1999;
  17. Sapolsky RM. Why stress is bad for your brain. Science. 1996;273:749–750
  18. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043–1049
  19. Scott BW, Wojtowicz JM, Burnham WM. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol. 2000;165:231–236
  20. Hellsten J, Wennstrom M, Mohapel P, Ekdahl CT, Bengzon J, Tingstrom A. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci. 2002;16:283–290
  21. Hellsten J, West MJ, Arvidsson A, Ekstrand J, Jansson L, Wennstrom M, et al. Electroconvulsive seizures induce angiogenesis in adult rat hippocampus. Biol Psychiatry. 2005;58:871–878
  22. Wennstrom M, Hellsten J, Ekstrand J, Lindgren H, Tingstrvm A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry. 2006;59:178–186
  23. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Klauminzer G, Charney DS, et al. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav Ther. 1990;13:187–188
  24. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8:75–90
  25. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837–1844
  26. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485–492
  27. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62:860–868
  28. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006;26:259–267Erratum in: J Clin Psychopharmacol. 2006;26:473
  29. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006;63:1158–1165
  30. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389
  31. Guy W. Assessment Manual for Psychopharmacology, Revised. US Dept of Health, Education, and Welfare Publication (ADM) 76-368. Rockville, MD: National Institute of Mental Health; 1976;218-222
  32. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001;13:132–156
  33. Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu S-C, Capece JA, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007;68:201–206
  34. Margoob MA, Ahmad SA. Community prevalence of adult posttraumatic stress disorder in South Asia: experience from Kashmir. JK-Practitioner. 2006;13(Suppl 1):S18–S25
  35. Ali Z, Margoob MA, Dar MM, Hussain A. First report of PTSD in disturbed Kashmir: characteristics of a treatment-seeking sample. Poster presented at the 17th Annual Meetingof the International Society for Traumatic Stress Studies, New Orleans, Louisiana, USA, 2001.
  36. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982–1988
  37. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:190–195
  38. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007;68:711–720
  39. Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008;69:400–405
  40. Hamner MB. Psychotic features and combat associated PTSD. Depress Anxiety. 1997;5:34–38
  41. Hamner MB, Frueh BC, Ulmer HG, Arana GW. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999;45:846–852
  42. David D, Kutcher GS, Jackson EI, Mellman TA. Psychotic symptoms in combat-related posttraumatic stress disorder. Journal of Clinical Psychiatry. 1999;60:29–32
  43. Lindley SE, Carlson E, Sheikh J. Psychotic symptoms in posttraumatic stress disorder. CNS Spectr. 2000;5:52–57
  44. Kendell RE. The present status of electroconvulsive therapy. Br J Psychiatry. 1981;139:265–283
  45. Andrade C. Quantifying the ECT dose: the right unit remains elusive. J ECT. 2001;17:75

PII: S1935-861X(09)00054-0

doi: 10.1016/j.brs.2009.04.005

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 1 , Pages 28-35 , January 2010

Article Tools